A clinical trial of HER2.taNK cell therapy in patients with solid tumours
Latest Information Update: 15 Feb 2022
At a glance
- Drugs HER2 taNK (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 15 Feb 2018 New trial record
Latest Information Update: 15 Feb 2022